Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Germ Cell and Embryonal » Neuroectodermal Tumors » Neuroendocrine Tumors » Carcinoma, Neuroendocrine
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma » Adenocarcinoma » Carcinoma, Neuroendocrine
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Nerve Tissue » Neuroectodermal Tumors » Neuroendocrine Tumors » Carcinoma, Neuroendocrine
Description
A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round "blue cells", granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small ("oat") cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992) MeSH
Hierarchy View
Subtype Terms (4)
Carcinoma, Medullary
1 approved drug
Carcinoma, Merkel Cell
91 drugs (36 approved, 55 experimental)
Somatostatinoma
16 drugs (12 approved, 4 experimental)
Vipoma
10 drugs (8 approved, 2 experimental)
Phase 2 Indicated Drugs (45)
Phase 1 Indicated Drugs (8)
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (105)
Advanced Accelerator Applications
Australasian Gastro-Intestinal Trials Group
Chinese Academy of Medical Sciences
ECOG-ACRIN Cancer Research Group
European Organisation for Research and Treatment of Cancer
Excel Diagnostics and Nuclear Oncology Center
Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)
Grupo Espanol de Tumores Neuroendocrinos (GETNE)
Gruppo Oncologico Italiano di Ricerca Clinica
Institut National de la Santé Et de la Recherche Médicale, France
Intergroupe Francophone de Cancerologie Thoracique
Istituto Nazionale per lo Studio e la Cura dei Tumori
Ligue contre le cancer, France
Melanoma and Skin Cancer Trials Limited
National Cancer Institute (NCI)
National Cheng Kung University
Radio Isotope Therapy of America
Salient Pharmaceuticals Incorporated
Specialised Therapeutics Australia
State University of New York, Buffalo
Taichung Veterans General Hospital
Taipei Veteran General hospital
Organization Involved with Phase 1 Indications (16)
Organization Involved with Other Experimental Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
